DocDollars

Biofrontera Inc.

MA · United States · Reporting entity ID 100000151660

Total reported 2019–2025
$4.40M
#754 of 2,960 reporting companies — 0% of all reported industry payments
$1.39M in general payments across 27,361 records, plus $3.01M in research funding across 324 records.

How it breaks down

General payments $1,389,315
Research funding $3,008,525

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Biofrontera Inc. reported $4.40M to US doctors and teaching hospitals from 2019 to 2025, ranking #754 of 2,960 reporting companies. 68% of that was research funding and 32% general payments such as consulting, speaking, food and travel. 27,361 general payment records and 324 research records were filed.

Common questions about Biofrontera Inc.

How much has Biofrontera Inc. paid US doctors?

Biofrontera Inc. reported $4,397,839 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $1,389,315 in general payments, $3,008,525 in research funding.

How does Biofrontera Inc. rank among drug and device companies?

It ranks #754 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Biofrontera Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.